Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Murphy

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Public Health|July 26, 2023
Public health infection prevention: An analysis of existing training during the COVID-19 pandemicS Burton, T Landers, M Wilson, et al.
The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.
Archives of Disease in Childhood|April 1, 1994
Brain swelling and ischaemia in Kenyans with cerebral malariaC R Newton, N Peshu, B Kendall, et al.
Mutation Research|November 1, 1988
1,3-Butadiene: induction of micronucleated erythrocytes in the peripheral blood of B6C3F1 mice exposed by inhalation for 13 weeksP P Jauhar, P R Henika, J T MacGregor, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarctionC M Gibson, A J Kirtane, S A Murphy, et al.
The American Journal of Cardiology|December 13, 2000
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, S A Murphy, et al.
British Journal of Clinical Pharmacology|March 1, 1995
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malariaW M Watkins, P A Winstanley, E K Mberu, et al.
European Heart Journal|May 15, 2015
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialJ Steffel, R P Giugliano, E Braunwald, et al.
Circulation|May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudyC M Gibson, J A de Lemos, S A Murphy, et al.
Lancet (London, England)|November 22, 2001
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudyD A Morrow, E M Antman, R P Giugliano, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Public Health|July 26, 2023
Public health infection prevention: An analysis of existing training during the COVID-19 pandemicS Burton, T Landers, M Wilson, et al.
The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.
Archives of Disease in Childhood|April 1, 1994
Brain swelling and ischaemia in Kenyans with cerebral malariaC R Newton, N Peshu, B Kendall, et al.
Mutation Research|November 1, 1988
1,3-Butadiene: induction of micronucleated erythrocytes in the peripheral blood of B6C3F1 mice exposed by inhalation for 13 weeksP P Jauhar, P R Henika, J T MacGregor, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarctionC M Gibson, A J Kirtane, S A Murphy, et al.
The American Journal of Cardiology|December 13, 2000
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, S A Murphy, et al.
British Journal of Clinical Pharmacology|March 1, 1995
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malariaW M Watkins, P A Winstanley, E K Mberu, et al.
European Heart Journal|May 15, 2015
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialJ Steffel, R P Giugliano, E Braunwald, et al.
Circulation|May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudyC M Gibson, J A de Lemos, S A Murphy, et al.
Lancet (London, England)|November 22, 2001
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudyD A Morrow, E M Antman, R P Giugliano, et al.
Pageof 11